CSRxP Applauds Grassley, Wyden for Moving Ahead on Drug Pricing Package

07-23-2019 Press Release

Looks Forward to Working With Senate Finance Members to Hold Big Pharma Accountable For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]   Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday commending Chairman Chuck Grassley (R-IA) and Ranking Member Ron Wyden (D-OR) for moving ahead with a U.S. Senate Committee […]

Big Pharma Earnings Watch: Novartis

07-18-2019 Press Release

Drug Makers’ Shares Hit ‘All-Time High’ Off Of Price-Gouging American Patients Today Big Pharma giant Novartis announced better-than-expected earnings for the second quarter of 2019. The brand name drug maker reported $11.76 billion in sales in Q2 – up from $11.34 billion last year – beating analysts’ expectations. As a result, the company raised its […]

Big Pharma Earnings Watch: Johnson & Johnson

07-17-2019 Press Release

Drug Maker Bests Q2 Forecasts After Hiking Prices on Dozens of Drugs in 2019 It’s that time again. Pharmaceutical companies are starting to report their earnings for Q2. Big Pharma giant Johnson & Johnson out of the gate Tuesday. The brand name drug maker announced better-than-expected second quarter earnings and raised its sales forecast for […]

CSRxP Encourages House E&C Lawmakers to Advance FAIR Drug Pricing Act

07-16-2019 Press Release

Greater List Price Transparency Will Help Hold Big Pharma Accountable, Deter Price-Gouging For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today encouraging the U.S. House Committee on Energy & Commerce to advance the FAIR Drug Pricing Act being considered in a markup […]

Big Pharma Watch: Manufacturers Thumb Nose at Drug Price Crisis

07-12-2019 Press Release

Drug Makers Continue Price-Gouging Patients as Americans Demand Accountability The summer is heating up and so too is Big Pharma’s zeal for putting profits over people. Brand name drug makers kicked off the mid-year months with price hikes on hundreds of drugs. Big Pharma’s summer price-gouging bonanza builds on the industry’s rapid pace of price […]

CSRxP Applauds Administration for Withdrawal of Controversial Rebate Rule

07-11-2019 Press Release

Decision to Sideline Misguided Proposal a Huge Win for America’s Seniors & Taxpayers, Loss for Big Pharma For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today reacting to the administration’s decision to withdraw a proposal from the Department of Health and Human Services […]

CSRxP: Judiciary Committee Cracks Down on Big Pharma’s Anti-Competitive Tactics

06-27-2019 Press Release

Senators Advance Three Measures to Help Lower Drug Prices as Momentum to Hold Drug Makers Accountable Builds For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement praising lawmakers on the U.S. Senate Committee on the Judiciary for advancing three important measures to […]

CSRxP Applauds Senate HELP Committee For Advancing Bipartisan Measures to Hold Big Pharma Accountable and Lower Drug Prices

06-26-2019 Press Release

Advancement of CREATES and FAIR Drug Pricing Acts Marks Step Toward Boosting Competition and Transparency For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) today released a statement praising lawmakers on the U.S. Senate Health, Education, Labor and Pensions (HELP) Committee for taking up and advancing […]

Two Birds of a Feather: AbbVie to Acquire Fellow Price-Gouger Allergan In Multi-Billion Dollar Deal

06-26-2019 Press Release

This week, Big Pharma giant AbbVie announced plans to acquire drug maker Allergan in a $63 billion merger. AbbVie, the maker of top-selling drug in the U.S. Humira, notched over $32 billion in revenue in 2018, while Allergan, best known for manufacturing Botox, made nearly $16 billion in annual revenue. What do AbbVie and Allergan […]

CSRxP Applauds HELP Committee for Taking Up Bipartisan CREATES Act

06-25-2019 Press Release

Encourages Senate Panel to Further Strengthen Drug Price Package with REMEDY and FAIR Drug Pricing Acts For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today ahead of a U.S. Senate Health, Education, Labor and Pensions (HELP) Committee legislative markup of its drug […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.